We are live on
!
Find out more
ARTA
A.R.T. Advisors Portfolio holdings
AUM
$1.79M
1-Year Est. Return
57.47%
This Fund
S&P 500
This Quarter
Est. Return
-9.43%
1 Year Est. Return
+57.47%
3 Year Est. Return
+81.79%
5 Year Est. Return
+178.88%
10 Year Est. Return
–
AUM
$2.7B
AUM Growth
-$296M
(-9.9%)
Cap. Flow
+$44.6M
Cap. Flow
% of AUM
1.65%
Top 10 Holdings %
Top 10 Hldgs %
8.27%
Holding
1,895
New
457
Increased
377
Reduced
454
Closed
575
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$26.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$24.9M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$19.8M |
| 4 |
Morgan Stanley
MS
|
+$18.5M |
| 5 |
Kraft Heinz
KHC
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cencora
COR
|
+$22.3M |
| 2 |
Amgen
AMGN
|
+$21.9M |
| 3 |
Alibaba
BABA
|
+$18.9M |
| 4 |
SLB Ltd
SLB
|
+$18M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.76% |
| 2 | Technology | 13.33% |
| 3 | Consumer Discretionary | 12.45% |
| 4 | Industrials | 11.02% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Western Alliance Bancorporation
WAL
$9.13B
| $1.45M | 0.05% |
+47,165
| New | +$1.53M |
|
502
Inogen
INGN
$174M
| $1.45M | 0.05% |
+29,808
| New | +$1.42M |
|
|
RLYP
503
DELISTED
RELYPSA INC COM
RLYP
| $1.44M | 0.05% |
+77,825
| New | +$2.14M |
|
504
Karyopharm Therapeutics
KPTI
$161M
| $1.43M | 0.05% |
+9,074
| New | +$2.43M |
|
505
HubSpot
HUBS
$12.2B
| $1.43M | 0.05% |
30,867
-746
| -2% | -$36.5K |
|
506
Synaptics
SYNA
$4.33B
| $1.41M | 0.05% |
+17,122
| New | +$1.29M |
|
|
ADVM
507
DELISTED
Adverum Biotechnologies
ADVM
| $1.41M | 0.05% |
17,120
+7,093
| +71% | +$906K |
|
508
Greif
GEF
$4.74B
| $1.41M | 0.05% |
+44,202
| New | +$1.44M |
|
509
Robert Half
RHI
$4.04B
| $1.41M | 0.05% |
27,556
-28,798
| -51% | -$1.55M |
|
510
Darling Ingredients
DAR
$9.28B
| $1.41M | 0.05% |
125,188
+55,101
| +79% | +$704K |
|
|
LSI
511
DELISTED
Life Storage, Inc.
LSI
| $1.4M | 0.05% |
22,280
+10,614
| +91% | +$656K |
|
512
Brookdale Senior Living
BKD
$3.67B
| $1.39M | 0.05% |
60,595
-57,527
| -49% | -$1.7M |
|
|
CHUY
513
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.39M | 0.05% |
48,849
+14,342
| +42% | +$426K |
|
514
Revvity
RVTY
$12.4B
| $1.39M | 0.05% |
+30,149
| New | +$1.5M |
|
515
Dine Brands
DIN
$458M
| $1.38M | 0.05% |
15,044
+3,188
| +27% | +$311K |
|
|
TVRD
516
Tvardi Therapeutics
TVRD
$22.9M
| $1.38M | 0.05% |
+2,676
| New | +$1.79M |
|
517
NETGEAR
NTGR
$663M
| $1.37M | 0.05% |
+47,037
| New | +$1.43M |
|
|
DBVT
518
DBV Technologies
DBVT
$799M
| $1.36M | 0.05% |
3,836
+1,378
| +56% | +$542K |
|
519
Beazer Homes USA
BZH
$913M
| $1.36M | 0.05% |
+102,270
| New | +$1.78M |
|
520
Papa John's
PZZA
$1.02B
| $1.36M | 0.05% |
19,865
+13,369
| +206% | +$963K |
|
|
WBMD
521
DELISTED
WebMD Health Corp.
WBMD
| $1.35M | 0.05% |
33,980
+9,173
| +37% | +$388K |
|
|
MKTO
522
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $1.35M | 0.05% |
+47,515
| New | +$1.34M |
|
|
ISLE
523
DELISTED
Isle of Capri Casinos Inc
ISLE
| $1.34M | 0.05% |
77,137
-12,894
| -14% | -$239K |
|
524
First Industrial Realty Trust
FR
$8.77B
| $1.34M | 0.05% |
63,965
+16,220
| +34% | +$326K |
|
525
Hancock Whitney
HWC
$6.19B
| $1.34M | 0.05% |
49,543
-53,152
| -52% | -$1.51M |
|
Similar funds
MA
FFIM
LC
YEPV
AAM
CCM
IR
IFC
A.R.T. Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, A.R.T. Advisors held 1,895 positions worth $2.7B, down 9.9% from $3B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
A.R.T. Advisors's Q3 2015 filing shows 457 new, 377 increased, 454 reduced and 575 closed positions. Its largest new stake was Teva Pharmaceuticals: 414,963 shares worth $23.4M. The largest sale was Cencora, an estimated $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
- A.R.T. Advisors's largest Q3 2015 buy was Teva Pharmaceuticals: 414,963 shares worth $23.4M.
- A.R.T. Advisors added most to Alphabet (Google) Class C in Q3 2015, an estimated $24.9M increase.
- A.R.T. Advisors's biggest Q3 2015 reduction was Cencora, cutting an estimated $22.3M.
- A.R.T. Advisors fully exited Alibaba in Q3 2015, selling an estimated $18.9M.
- A.R.T. Advisors's ten largest holdings make up 8.3% of its $2.7B portfolio in Q3 2015.
- A.R.T. Advisors opened 457 new positions and closed 575 in Q3 2015.
- A.R.T. Advisors's portfolio value fell 9.9% quarter-over-quarter to $2.7B.
Based on A.R.T. Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.